Structurally unique PARP‐1 inhibitors for the treatment of prostate cancer
Abstract The prognosis for metastatic castration‐resistant prostate cancer is unfavorable, and although Poly(ADP)‐ribose polymerase‐1 (PARP‐1) inhibitors have shown efficacy in the treatment of androgen‐receptor dependent malignancies, the limited number of options present obstacles for patients tha...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | |
| Опубликовано: |
Wiley,
2020-04-01T00:00:00Z.
|
| Предметы: | |
| Online-ссылка: | Connect to this object online. |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Internet
Connect to this object online.3rd Floor Main Library
| Шифр: |
A1234.567 |
|---|---|
| Копировать 1 | Доступно |